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joint disease. Recently, one of our research groups discovered that the
small molecule kartogenin (KGN) promotes chondrocyte differentiation
fromadultmesenchymal stemcells andenhancesarticularcartilage repair
in adult mouse models of OA. What has remained unknown, however, is
whether KGNmay be able to stimulate the development of synovial joints
and formation of their unique tissues during embryogenesis. Here, we
used an ex vivo system to evaluate the inﬂuence of KGN on synovial joint
formation in reporter-expressing mouse embryo limb explants.
Methods: Female Gdf5-Cre transgenic mice were mated with male
ROSA-mTomato/mGFP reporter mice which express constitutive red
ﬂuorescence prior to, and conditional green ﬂuorescence following,
Cre-mediated recombination. Resulting embryos were harvested at
embryonic day 12 or 13 (E12 or E13). After harvest, limbs were main-
tained in explant culture containing DMEM + 1% FBS for 96h. Limbs
were treated with DMSO (vehicle control) or 100nM KGN and imaged
every 24h using ﬂuorescent microscopy. After 96h, limbs were pro-
cessed for whole mount alcian blue staining or cryo-sectioning.
Results: In previous studies, we showed that Gdf5-expressing mesen-
chymal interzone cells form at presumptive limb joint sites and even-
tually give rise to all joint tissues over time, including articular cartilage,
ligaments and synovial lining. Indeed, Gdf5-Cre driven mGFP reporter
signal was still absent in early E12 hind autopods at harvesting (Fig. 1, A,
E). By 96h in control DMSO-treated explants, mGFP signal had become
appreciable in the incipient metatarsal/proximal phalangeal joint site of
digits 2-4 (Fig. 1B, arrowhead) as expected. Alcian blue staining showed
that the cartilaginous metatarsals (MT) were well developed, while the
proximal phalanges (PP) were rudimentary (Fig. 1C). Strikingly, KGN
treatment of companion limb explants had induced strong growth of the
proximal cartilaginous phalanges as well as formation of the next prox-
imal-medial phalangeal joint as indicated by mGFP signal (Fig. 1F,
arrows). The strength of KGN effects was reiterated by the fact that
whereas digit 5 was hardly developed in controls (Fig. 1C, arrowhead), it
was well organized and elongated in treated specimens (Fig. 1G,
arrowhead). As the joints form, the mesenchymal interzone cells
undergo a process of migration and condensation. Confocal analysis
revealed that while the mGFP-positive cells at putative joint sites in
DMSO-treated controls were broadly distributed and randomly oriented
(Fig. 1D), the cells in KGN-treated specimens had undergone condensa-
tion andwere all aligned transverse to the limb longitudinal axis (Fig.1H).
Conclusions: Our data provide clear evidence that KGN is a strong stim-
ulator of joint formation and interzone function and sustains these
complexprocesses inexvivomouseembryo limbs.KGNalsostimulates the
growth and elongation of the cartilaginous phalangeal elements, reiter-
ating its pro-chondrogenic abilities ﬁrst revealed by our previous studies
and pointing to plausible additional properties in limb regeneration.
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IL-1b AND TNF-a REGULATE THE GLOBAL HYDROXYMETHYLATION
OF GENOMIC DNA BY MODULATING THE EXPRESSION AND
ACTIVITY OF TET-1 IN HUMAN OA CHONDROCYTES
A. Haseeb, T.M. Haqqi. NEOMED Univ., Dept. Anatomy & Neurobiology,
Rootstown, OH, USA
Purpose: 5-methylcytosine (5-mC) is a widely studied epigenetic DNA
mark that play important roles in gene regulation, cell differentiation
and organ development. Recently, 5-hydroxymethylcytosine (5-hmC)
was discovered as a new DNA mark most abundantly present in brainand in embryonic stem cells. 5-hmC is formed as a result of oxidation of
5-mC by a family of ten-eleven translocation (TET) proteins. 5-hmC is
considered as an intermediate in DNA demethylation as well as
a distinct DNA mark per se. There is increasing evidence that 5-hmC,
like 5-mC, may also be important in epigenetic control of gene
expression during development and disease. In the present study we
investigated the role of pro-inﬂammatory cytokines IL-1b and TNF-a in
regulating the global 5-hmC levels in the genomic DNA as well as at
a speciﬁc locus in MMP-3 promoter region in human OA chondrocytes.
We also investigated the effect of IL-1b and TNF-a on the expression and
activity of the enzymes involved in the generation of 5-hmC, including
TETs and iso-citrate dehydrogenases (IDHs).
Methods: Primary human chondrocytes were isolated from the deep
zone of the cartilage obtained from OA patients who underwent total
joint replacement (n¼8). Global 5-hmC content in the genomic DNA
was quantiﬁed using a 5-hmC-speciﬁc ELISA (Epigentek, Farmingdale,
NY). Total TET activity was determined by an ELISA based activity assay
kit (Epigentek). Total IDH activity was determined by a colorimetric
assay kit (Sigma Aldrich, St Louis, MO). Gene expression of MMP-3, TET-
1, TET-2, TET-3, IDH-1 and IDH-2 was quantitated using the TaqMan
assays (Applied Biosystems, Carlsbad, CA). Locus speciﬁc 5-mC and 5-
hmC content in the promoter region of MMP-3 gene was examined by
restriction digestion by methylation and glucosylation sensitive
enzymes followed by PCR using speciﬁc primers. Data were derived
using Origin 6.1 software and P<0.05 was considered signiﬁcant.
Results: The global 5-hmC content in human chondrocytes was found to
be 0.1-0.2% of the total genomic DNA. There was approximately 70%
decrease (P<0.05) in the 5-hmC content upon treatment with IL-1b plus
TNFa for 48 hrs. This correlatedwith the reduction of Tet enzyme activity
after treatment with IL-1b alone or with IL-1b + TNF-a. There was
a signiﬁcant (upto 20 fold) reduction in the level of Tet-1 mRNA
expression while expression of Tet-3 mRNA was increased slightly (2-3
fold). The level of Tet-2mRNAexpression did not change upon treatment
with the cytokines. IL-1b and TNF-a down-regulated the IDH-1 and IDH-
2mRNAexpression anddecreased total IDH enzymatic activity in human
chondrocytes. We found that the MMP-3 promoter region DNA was
hypermethylated (w90%) and that about 50% of the cytosine were
hydroxymethylated at HpaII locus. There was approximately 8-fold
decrease in the level of 5-hmC upon treatment with IL-1b and TNF-a at
TaqI locus in the MMP-3 promoter region. This cytokine-induced hypo-
hydroxymethylation correlated with approximately 40-fold increase in
mRNA expression of MMP-3 upon treatment with both IL-1b and TNF-a.
Conclusions: Our results demonstrate for the ﬁrst time the presence of
a signiﬁcant amount of 5-hmC in human chondrocyte DNA. We also for
the ﬁrst time show that pro-inﬂammatory cytokines IL-1b and TNF-
amodulate the 5-hmC content in the genomic DNA via modulating the
gene expression and activities of TET and IDH enzymes. Taken together
our novel data (a) suggests that DNA hydroxymethylation of critical
genes implicate epigenetic modiﬁcations to cytokine mediated gene
expression and may contribute to the pathogenesis of OA; and (b)
identify novel targets for the development of OA therapeutics.15
VISFATIN/NAMPT IN OSTEOARTHRITIS: A PRO-INFLAMMATORY
ADIPOKINE INVOLVED IN SYNOVIUM-CARTILAGE AND SYNOVIUM-
BONE COMMUNICATIONS
M.-C. Laiguillon y, C. Bougault y, M. Gosset z, G. Nourissat y,x, S. Priam y, C.
Jacques y, X. Houard y, F. Berenbaum y,k, J. Sellam y,k. yUR4 UPMC, Paris,
France; z EA 2496, Paris Descartes Univ., Paris, France; xDept. of
Orthopaedic Surgery and Traumatology, Saint-Antoine Hosp., AP-HP,
UPMC, Paris, France; kRheumatology Dept., Saint-Antoine Hosp., AP-HP,
UPMC, Paris, France
Purpose: Visfatin, in homodimeric conformation, exerts a nicotinamide
phosphoribosyltransferase (NAMPT) enzymatic activity, which is the
rate-limiting stage in the salvage pathway of nicotinamide adenine
dinucleotide (NAD) biosynthesis from nicotinamide. NAD is involved in
many biological processes including redox reactions, sirtuins activity
and TNFa synthesis. In this study, we aimed to i) characterize the sites of
visfatin/NAMPT production in human OA joint tissues, ii) assess ex vivo
its enzymatic activity iii) investigate the role of this NAMPT enzymatic
activity in chondrocytes and subchondral bone activations.
Methods: Human OA joint tissues (synovial membrane, cartilage, sub-
chondral bone) from patients undergoing surgical knee replacement
Table 1
PCA with varimax rotation for 11 different sites on CE-MRI, component loading*
Anatomical sites of synovitis on CE-MRI Components
1 2 3 4
Adjacent to posterior cruciate ligament site 0.762
Suprapatellar site 0.762
Intercondylar site (at surface of Hoffa's
fat pad)
0.720
Lateral parameniscal site 0.461 0.454
Medial parapatellar site 0.821
Lateral parapatellar site 0.791
Baker Cyst 0.635
Adjacent to the anterior cruciate ligament 0.806
Medial parameniscal site 0.746
Loose Body 0.832
Infra patellar site -0.707
% variance explained 23% 20% 12% 12%
* Note: only loadings >0.4 are displayed
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conformation and release inmedia by the different tissueswas evaluated
using Western Blot (WB) and ELISA, respectively. In parallel, proteins
were extracted from frozen joint tissues to assess the in situ production
and conformation of visfatin/NAMPT by WB. NAMPT enzymatic activity
was also assessed in OA synovium using Cyclex colorimetric assay.
Primary cultures of mouse chondrocytes and osteoblasts were stimu-
latedwith recombinant visfatin/NAMPT (5 mg/mL) for 24h. To determine
in vitro the role of the NAMPT activity, cells were pretreated or not 4h
before visfatin/NAMPT stimulation with APO866 (10nM), a pharmaco-
logic inhibitor of NAMPT activity (1). Effects of stimulation on IL-6, IL-8/
Kc, MCP-1, VEGF and TGFb expression, and on IL-6, IL-8/Kc and MCP-1
release were examined by quantitative RT-PCR and ELISA, respectively.
Results: All human OA joint tissues released visfatin/NAMPT (syno-
vium: 529 356, cartilage: 237 380, subchondral bone: 195 92 ng/g
tissue) with higher level for the synovium compared to cartilage and
subchondral bone (p<0.01). In tissular explants and conditionnated
media, visfatin/NAMPT was found as a homodimer, corresponding to
the enzymatically active conformation. Moreover, NAMPT activity was
identiﬁed ex vivo in synovium and characterized by a reaction velocity
at 1.38E-3  8E-4 min-1 (n¼3). Visfatin/NAMPT signiﬁcantly induced IL-
6, IL-8/Kc and MCP-1 gene expressions and protein productions by
chondrocytes and osteoblasts (n[6) (Table). Nampt activity inhibi-
tion by APO866 decreased pro-inﬂammatory cytokines expression
atmRNA level (up to 94 % of inhibition) as well as at protein level (up
to 63 % of inhibition) and was especially efﬁcient in chondrocytes
(Table). VEGF and TGFb expression were unchanged upon stimulation,
suggesting that visfatin/NAMPT has selective properties.
Conclusions:Visfatin/NAMPT is releasedbyall OA tissuesunder a dimeric
enzymatically active conformation and mostly by the synovium which
displays a detectable NAMPT activity. The NAMPT activity of visfatin is
involved in chondrocytes and osteoblasts activation, suggesting that tar-
geting its enzymatic activity with a compound like APO866 (being tested
in hematological malignancies) may be a new therapeutic approach.Gene expression Protein production
IL-6 Kc/IL-8 MCP-1 IL-6 Kc/IL-8 MCP-1
Chonodrocytes
(n ¼ 6)
Fold induction after visfatin/NAMPT
stimulation (Mean  SEM), p-value
10.6  3
(p ¼ 0.015)
4.9  1.3
(p ¼ 0.015)
2.5  0.4
(p ¼ 0.03)
5.8  5
(p ¼ 0.016)
29.7  33
(p ¼ 0.015)
10.5  2
(p ¼ 0.016)
Mean % of inhibition by APO866, p-value 94 %
(p ¼ 0.015)
83 %
(p ¼ 0.015)
62 %
(p ¼ 0.015)
63 %
(p ¼ 0.016)
57 %
(p ¼ 0.031)
54 %
(p ¼ 0.016)
Osteoblasts
(n ¼ 6)
Fold induction after visfatin/NAMPT
stimulation (Mean  SEM), p-value
296  59
(p ¼ 0.031)
262  96
(p ¼ 0.016)
161  78
(p ¼ 0.016)
115  46
(p ¼ 0.016)
164  71
(p ¼ 0.016)
22  7
(p ¼ 0.031)
Mean SEM % of inhibition by APO866 63 %
(p ¼ 0.031)
86 %
(p ¼ 0.016)
84 %
(p ¼ 0.047)
31 %
(p ¼ 0.031)
34 %
(p ¼ 0.08)
41 %
(p ¼ 0.06)16
DIFFERENT PATTERNS OF SYNOVITIS AS SEEN ON CE-MRI IN
PATIENTS WITH KNEE OSTEOARTHRITIS
B. de Lange-Brokaar y, A. Ioan-Facsinay y, E. Yusuf y, W. Visser y, H.
Kroon y, G. van Osch z, A.-M. Zuurmond x, V. Stojanovic-Susulic k, J.
Bloem y, R. Nelissen y, T. Huizinga y, M. Kloppenburg y. y LUMC, Leiden,
Netherlands; z Erasmus MC, Rotterdam, Netherlands; x TNO, Leiden,
Netherlands; k Janssen Res. & Dev., LLC, Spring House, PA, USAPurpose: Synovitis is prevalent in knee OA and is an important deter-
minant of pain. To better understand the nature of synovitis and its
association with pain we investigated patterns of synovitis on contrast
enhanced (CE) MRI and its relation to pain.
Methods:43patients (mean (SD)age60(21)years, 63%woman,BMI30(5)
kg/mm2, median (IQR) Kellgren-Lawrence score 3 (2-4)) with symptom-
atic knee OA attending the rheumatology or orthopaedic outpatient clinic
were included. 22 patients underwent arthroscopy and 21 arthroplasty.
Sagittal and axial T1-weighted CE MRI images (3T) were used to semi-
quantitatively score synovitis at 11 sites (total range 0-22) according to
Guermazi et al. (Ann RheumDis 2011). Self-reported painwas assessed by
visual analogue scale (VAS, 0-100), knee injuryand osteoarthritis outcome
score (KOOS (subscale pain),0-100) and measure of intermittent and
constant osteoarthritis pain (ICOAP, intermittent pain (0-100), constant
pain (0-100)). Principal component analysis (PCA) with varimax rotation
and Keiser Normalizationwas used to investigate patterns of synovitis for
all patients. A factor was said to load signiﬁcantly on a component whenloading exceeded 0.4. Subsequently, different patterns were associated
with pain measures in linear regression analysis adjusted for age, sex and
BMI, using SPSS 20.0. Log transformations were used when appropriate.
Results: A mild synovitis was observed (mean (SD) 8.0 (3.7)). Mean (SD)
KOOS pain was 49.6 (23.6) and ICOAP intermittent pain 42.0 (21.8).
Median (IQR) VASwas 57.0 (37-68) and ICOAP constant pain 35.0 (20-55).
PCA resulted in extraction of 4 components (Eigen value > 1), explaining
67% of variance (Table 1). Component 2 associated with KOOS pain and
ICOAP constant pain, not with VAS and ICOAP intermittent pain.
Component 3 associatedwithVASpain andnotwith other painmeasures.
Component 1 and 4 did not associate with any of the pain measures.
Conclusion: Different patterns of synovitis in knee OA were observed.
Results suggest that pain depends on synovitis pattern.17
HIGH SERUM-CHOLESTEROL LEVELS BY EITHER LOW DENSITY
LIPOPROTEIN RECEPTOR DEFICIENCY OR A CHOLESTEROL-RICH
DIET RESULTS IN SYNOVIAL ACTIVATION AND OSTEOPHYTE
FORMATION DURING EXPERIMENTAL OSTEOARTHRITIS
W. de Munter, A.W. Slöetjes, B. Walgreen, M.M. Helsen, W.B. van den
Berg, P.L. van Lent. Radboud Univ. Nijmegen Med. Ctr., Nijmegen,
Netherlands
Purpose: Recently, we have shown that synovial activation plays an
important role in etiopathology of osteoarthritis (OA). Synovial
macrophages are involved in cartilage damage and are crucial for
osteophyte formation in experimental OAmodels. Increased cholesterol
levels have been correlated to OA pathology suggesting a metabolic
mechanism. Atherosclerotic studies show that scavenger receptors on
macrophages are capable of taking up oxidized low density lipoprotein
(oxLDL), resulting in increased inﬂammatory properties of the macro-
phage. Accumulated LDL can be oxidized in an inﬂammatory milieu
such as OA, possibly resulting in oxLDL uptake of synovial macrophages.
We investigated whether increased LDL levels could lead tomore severe
OA pathology in experimental induced OA.
Methods: LDL receptor deﬁcient (LDLr-/-) mice and their wild type (WT)
controls received either a cholesterol-rich or control diet for 120 days
(n¼10 mice per group). Experimental OAwas induced by intra-articular
injection of collagenase on day 84 and 86. 36 days after OA induction,
mice were sacriﬁced and total knee joints (for histological analysis) and
serum were collected. Cartilage damage, synovial thickening and
